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prevented onset of CAN and associated death and provided
longlasting benefit in terms of graft survival. Exogenous HGF is
very unstable in the blood circulation due to the rapid clearance
by the liver. To circumvent this problem, we developed a new
gene transfer system by electroporation in vivo. Therefore, this
gene transfer approach represents a useful technique to inves-
tigate the therapeutic potential of HGF gene transfer for long-
term survival of kidney allograft. The goal of the present study
was to assess the renoprotective potential and safety of HGF
gene transfer using a porcine kidney transplant warm ischemia
injury model or CsA nephrotoxicity model. In the first set of ex-
periments, following left porcine kidney removal, 10 minutes of
warm ischemic injury was intentionally induced. Next, the HGF
expression vector or vehicle was infused into the renal artery
with the renal vein clamped ex vivo, and electric pulses were dis-
charged using bathtub-type electrodes. Kidney grafts were then
transplanted after removing the right kidney. Histopathologic
examination of vehicle-transfected kidney transplant revealed
initial tubular injury followed by tubulointerstitial fibrosis. In
contrast, HGF-transfected kidneys showed no initial tubular
damage and no interstitial fibrosis at 6 months posttransplant.
In the next set of experiments, CsA was subcutaneously admin-
istered daily under low sodium diet, and HGF gene was trans-
ferred into skeletal muscle by electroporation on days 7 and 14.
We also examined the antiapoptotic mechanism of HGF using
human proximal tubular epithelial cells. HGF gene transfer res-
cued CsA-induced initial tubular injury, and suppressed intersti-
tial infiltration of endothelium-1 (ED-1)–positive macrophages
in CsA nephrotoxicity. In addition, HGF significantly inhibited
tubular cell apoptosis, and increased the number of proliferat-
ing tubular epithelial cells. In vitro studies suggest that HGF
executes the antiapoptotic function by enhancing the phospho-
rylation of Akt and Bcl-2. Northern blot analysis demonstrated
that HGF gene transfer suppressed cortical mRNA levels of
transforming growth factor-b (TGF-b). Consequently, HGF
gene transfer significantly reduced a striped interstitial pheno-
typic alteration and fibrosis. We conclude that electroporation-
mediated HGF gene transfection protects the kidney against
graft injury.
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For those with uremia, renal function is presently replaced by
dialysis or allotransplantation. Neither approach is ideal phys-
iologically and allotransplantation suffers from limited avail-
ability of donors. In the future, the need to replace or amplify
renal function may increase dramatically as molecular diagnosis
identifies those at risk for cancer and renal failure, and as small
impairments of renal function are found to increase cardiovas-
cular risk. The heightened demand for renal replacement may
be met by the development or advancement of technologies, in-
cluding stem cells, cloning, organogenesis, and xenotransplan-
tation. The ideal replacement of renal function, however, may
not be achieved by any one of the technologies, but rather by a
combination. Cloning, stem cells, organogenesis and xenotrans-
plantation can potentially be combined for replacement of re-
nal function. New technologies or combinations of technologies
for replacement or regeneration of renal function share certain
challenges. One challenge is the need to generate organs or
organ-like structures that exhibit adequate function. Another
challenge is that the achieving of adequate size engenders some
risk of tumor formation. Still another challenge stems from the
controversy regarding the capacity of stem cells to differentiate
or transdifferentiate and the possibility that fusion of stem cells
or their progeny with differentiated cells may contribute to re-
generation and histogenesis. The implications of cell fusion in
such systems were discussed.
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